Key takeaway
Pooling 8 trials with 1657 participants, app-based interventions lowered systolic blood pressure by 2.28 mmHg (95% CI: between 0.66 and 3.90 lower) and improved medication adherence (standardized mean difference 0.38) in people with hypertension. The blood pressure drop is small, and only 6 of the 8 trials contributed to it.
Study design
Evidence review
Reading basis
Published abstract
Reading focus
Design & applicability
The research question
Many people with hypertension do not follow their treatment plan, which raises their risk of heart attacks and strokes. The authors wanted to know whether smartphone apps that target lifestyle management improve blood pressure, medication adherence and lifestyle habits.
Who and how
Systematic review and meta-analysis following PRISMA guidelines. The authors searched databases for randomized controlled trials of app-based interventions in people with hypertension, and pooled the effects against control groups. Eight studies with 1657 participants were included. The abstract does not name the databases, the search dates or the types of apps.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Across 6 studies measuring systolic blood pressure, apps beat control: weighted mean difference -2.28 (95% CI: between 0.66 and 3.90 lower). The unit is not stated in the abstract, though it is presumably mmHg.
- 2Medication adherence was better with apps (standardized mean difference 0.38, 95% CI 0.26-0.50; P<.001), with low heterogeneity (I^2=0%).
- 3There was no difference between groups in physical activity.
Limits & uncertainty
- 1Only 8 trials were included, and just 6 measured systolic blood pressure, so the pooled estimate rests on few studies.
- 2The abstract gives no information on trial quality, follow-up length or how adherence was measured, and apps differed in what they did.
- 3The confidence interval for blood pressure starts only 0.66 below zero, so the true effect could be very small.
- 4The authors' conclusion that apps lead to reductions is stronger than a small pooled difference in a few trials can support. This reading is based on the abstract only.
What to take from it
A hypertension app may help some people take medication more consistently and may lower systolic blood pressure slightly, but it is not a replacement for medical treatment. The lack of change in physical activity suggests apps do not automatically make people more active. Decisions about medication or treatment belong with your clinician.
Reading your own data
If you use a blood pressure cuff with an app, measure at consistent times and in the same position, and judge changes by trends over weeks rather than single readings. Share the log with your clinician rather than adjusting medication yourself.
How to read this evidence
Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Background
Hypertension is a major cause of cardiovascular disease, which is the leading cause of premature death. People with hypertension who do not comply with recommended treatment strategies have a higher risk of heart attacks and strokes, leading to hospitalization and consequently greater health care costs. The smartphone, which is now ubiquitous, offers a convenient tool to aid in the treatment of hypertension through the use of apps targeting lifestyle management, and such app-based interventions have shown promising results. In particular, recent evidence has shown the feasibility, acceptability, and success of digital interventions in changing the behavior of people with chronic conditions.
Objective
The aim of this study was to systematically compile available evidence to determine the overall effect of smartphone apps on blood pressure control, medication adherence, and lifestyle changes for people with hypertension.
Methods
This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement guidelines. Databases were searched to identify randomized controlled trials related to the influence of an app-based intervention in people with hypertension. Data extracted from the included studies were subjected to a meta-analysis to compare the effects of the smartphone app intervention to a control.
Results
Eight studies with a total of 1657 participants fulfilled the inclusion criteria. Pooled analysis of 6 studies assessing systolic blood pressure showed a significant overall effect in favor of the smartphone intervention (weighted mean difference -2.28, 95% CI -3.90-0.66). Pooled analysis of studies assessing medication adherence demonstrated a significant effect (P<.001) in favor of the intervention group (standard mean difference 0.38, 95% CI 0.26-0.50) with low heterogeneity (I^(2)=0%). No difference between groups was demonstrated with respect to physical activity.
Conclusions
A smartphone intervention leads to a reduction in blood pressure and an increase in medication adherence for people with hypertension. Future research should focus on the effect of behavior coaching apps on medication adherence, lifestyle change, and blood pressure reduction.
Sources & attribution
The Effect of Smartphone App-Based Interventions for Patients With Hypertension: Systematic Review and Meta-Analysis.
Xu H, Long H.
JMIR mHealth and uHealth · 2020-10-19
DOI: 10.2196/21759 ↗PubMed · 33074161 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people
Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.
Journal of the American Heart Association
Five exercise types lowered resting blood pressure, isometric training the most
Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.
British Journal of Sports Medicine
A salt substitute lowered stroke, major cardiovascular events and death in rural China
In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.
The New England Journal of Medicine
Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation
Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.
The New England Journal of Medicine

